| Literature DB >> 30412503 |
Angel Piriz1,2, Dolly Reyes1,2, Atul Narkhede1, Vanessa A Guzman1, Fawad Viqar1, Irene B Meier1, Mariana Budge1, Pedro Mena1,2, Stephen Dashnaw3, Joseph Lee1,2,4, Christiane Reitz1,2,3,4,5, Jose Gutierrez5, Luis Campos6, Martin Medrano7, Rafael Lantigua1,2,8, Richard Mayeux1,2,4,5, Adam M Brickman1,2,5.
Abstract
The incidence and prevalence of Alzheimer's disease (AD) dementia are higher among Caribbean Hispanics than among non-Hispanic Whites. The causes of this health disparity remain elusive, partially because of the relative limited capacity for biomedical research in the developing countries that comprise Caribbean Latin America. To begin to address this issue, we were awarded a Development Research Award from the US NIH and Fogarty International Center in order to establish the local capacity to integrate magnetic resonance imaging (MRI) into studies of cognitive aging and dementia in Dominican Republic, establish collaborations with Dominican investigators, and conduct a pilot study on the role of cerebrovascular markers in the clinical expression of AD. Ninety older adult participants with and without AD dementia and with and without a strong family history of AD dementia received MRI scans and clinical evaluation. We quantified markers of cerebrovascular disease (white matter hyperintensities [WMH], presence of infarct, and presence of microbleed) and neurodegeneration (entorhinal cortex volume) and compared them across groups. Patients with AD dementia had smaller entorhinal cortex and greater WMH volumes compared with controls, regardless of family history status. This study provides evidence for the capacity to conduct MRI studies of cognitive aging and dementia in Dominican Republic. The results are consistent with the hypothesis that small vessel cerebrovascular disease represents a core feature of AD dementia, as affected participants had elevated WMH volumes irrespective of family history status.Entities:
Keywords: Alzheimer’s disease; cerebrovascular disease; developing countries; neurodegenerationzzm321990
Mesh:
Year: 2018 PMID: 30412503 PMCID: PMC6506181 DOI: 10.3233/JAD-180807
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472